Page last updated: 2024-08-25
chloropyramine hydrochloride and Breast Neoplasms
chloropyramine hydrochloride has been researched along with Breast Neoplasms in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Cance, WG; He, D; Hunt, DL; Kurenova, EV; Magis, AT; Ostrov, DA | 1 |
Other Studies
1 other study(ies) available for chloropyramine hydrochloride and Breast Neoplasms
Article | Year |
---|---|
Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.
Topics: Animals; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Ethylenediamines; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mice; Phosphorylation; Vascular Endothelial Growth Factor Receptor-3 | 2009 |